| 1. |
[J]. Int J Cancer, 2003; 104(4)∶ 482.
|
| 2. |
[J]. Clin Cancer Res, 2003; 9(7)∶2447.
|
| 3. |
|
| 4. |
[J]. Nihon Rinsho Meneki Gakkai Kaishi, 1997; 20(2)∶95.
|
| 5. |
[J]. J Korean Med Sci, 2002; 17(4)∶497.
|
| 6. |
[J]. Arch Pathol Lab Med, 1998; 122(6)∶551.
|
| 7. |
|
| 8. |
[J]. Ann Surg, 1996; 224(2)∶183.
|
| 9. |
[J]. Cancer Lett, 2004; 208(2)∶197.
|
| 10. |
Eichmuller S, Usener D, Thiel D, et al. Tumorspecific antigens in cutaneous Tcell lymphoma: expression and seroreactivity.
|
| 11. |
Ullenhag GJ, Frodin JE, Mosolits S, et al. Immunization of colorectal carcinoma patients with a recombinant canarypox virus expressing the tumor antigen EpCAM/KSA (ALVACKSA) and granulocyte macrophage colonystimulating factor induced a tumorspecific cellular immune response.
|
| 12. |
Nishimura S, Fujita M, Terata N, et al. Expression of MAGE genes in colorectal carcinomas.
|
| 13. |
Park MS, Park JW, Jeon CH, et al. Expression of melanoma antigenencoding genes (MAGE) by common primers for MAGEA1 toA6 in colorectal carcinomas among Koreans.
|
| 14. |
Hasegawa H, Mori M, Haraguchi M, et al. Expression spectrum of melanoma antigenencoding gene family members in colorectal carcinoma.
|
| 15. |
Mori M, Inoue H, Mimori K, et al. Expression of MAGE genes in human colorectal carcinoma.
|
| 16. |
Gerhardt A, Usener D, Keese M, et al. Tissue expression and seroreactivity of tumorspecific antigens in colorectal cancer.
|